JaySumanRavalMD
Pathology • Albuquerque, NMBlood Banking & Transfusion Medicine
Associate Professor and Director, Transfusion Medicine and Therapeutic Pathology, Department of Pathology, University of New Mexico
Dr. Raval is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2211 Lomas Blvd NE
Albuquerque, NM 87106- Is this information wrong?
Summary
- Dr. Jay Raval is a pathologist in Albuquerque, NM and is Director of Transfusion Medicine and
Therapeutic Pathology at the University of New Mexico. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine, received post-graduate training at the University of Pittsburgh Medical Center (UPMC), and has been in practice for 11 years. He specializes in blood banking, transfusion medicine, apheresis medicine, and cellular therapies.
Education & Training
UPMC Medical Education/Institute for Transfusion MedicineFellowship, Blood Banking/Transfusion Medicine, 2010 - 2011- UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 2007 - 2010
- UPMC Medical Education (Pittsburgh)Residency, Surgery, 2006 - 2007
University of North Carolina at Chapel Hill School of MedicineClass of 2006
Certifications & Licensure
NM State Medical License 2018 - 2025
NC State Medical License 2012 - 2020
PA State Medical License 2009 - 2012- American Board of Pathology Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.Han-Sol Park, Anna Yin, Caelan Barranta, John S Lee, Christopher A Caputo, Jaiprasath Sachithanandham, Maggie Li, Steve Yoon, Ioannis Sitaras, Anne Jedlicka, Yolanda E...> ;JCI Insight. 2024 Mar 14
- A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Metjian, Yara A Park, Gustaaf de Ridder, B...> ;Research and Practice in Thrombosis and Haemostasis. 2024 Mar 1
- Utilizing triple tandem extracorporeal membrane oxygenation, therapeutic plasma exchange, and continuous renal replacement therapy in a neonate with elevated plasma-fr...Senan Hadid, Jay S Raval> ;Therapeutic Apheresis and Dialysis. 2024 Jun 1
- Join now to see all
Journal Articles
- ADAMTS13: Origins, Applications, and ProspectsBrian S Zuckerbraun, Matthew D Neal, Jay S Raval, Mitchell R Dyer, Transfusion
Abstracts/Posters
- Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian PopulationsJay S Raval, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraJay S Raval, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Prolonged Circulation of Ultra-Large Von Willebrand Factor and a Reduction in ADAMTS13 Activity Promotes Microvascular Disease Following Traumatic InjuryJay S Raval, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hospital Affiliations
University of New Mexico HospitalsAlbuquerque, New Mexico
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
